{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T02:46:24Z","timestamp":1789613184758,"version":"build-2803163510"},"reference-count":63,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2015,2,17]],"date-time":"2015-02-17T00:00:00Z","timestamp":1424131200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Transcriptional activation of major histocompatibility complex (MHC) I and II molecules by the cytokine, interferon \u03b3 (IFN-\u03b3), is a key step in cell-mediated immunity against pathogens and tumors. Recent evidence suggests that suppression of MHC I and II expression on multiple tumor types plays important roles in tumor immunoevasion. One such tumor is malignant melanoma, a leading cause of skin cancer-related deaths. Despite growing awareness of MHC expression defects, the molecular mechanisms by which melanoma cells suppress MHC and escape from immune-mediated elimination remain unknown. Here, we analyze the dysregulation of the Janus kinase (JAK)\/STAT pathway and its role in the suppression of MHC II in melanoma cell lines at the radial growth phase (RGP), the vertical growth phase (VGP) and the metastatic phase (MET). While RGP and VGP cells both express MHC II, MET cells lack not only MHC II, but also the critical transcription factors, interferon response factor (IRF) 1 and its upstream activator, signal transducer and activator of transcription 1 (STAT1). Suppression of STAT1 in vitro was also observed in patient tumor samples, suggesting STAT1 silencing as a global mechanism of MHC II suppression and immunoevasion.<\/jats:p>","DOI":"10.3390\/ijms16024343","type":"journal-article","created":{"date-parts":[[2015,2,17]],"date-time":"2015-02-17T10:11:14Z","timestamp":1424167874000},"page":"4343-4361","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Metastatic Melanoma Cells Evade Immune Detection by Silencing STAT1"],"prefix":"10.3390","volume":"16","author":[{"given":"JoDi","family":"Osborn","sequence":"first","affiliation":[{"name":"Division of Cellular Biology and Immunology, Department of Biology, Georgia State University, Atlanta, GA 30303, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Greer","sequence":"additional","affiliation":[{"name":"Division of Cellular Biology and Immunology, Department of Biology, Georgia State University, Atlanta, GA 30303, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2015,2,17]]},"reference":[{"key":"ref_1","first-page":"83","article-title":"The developmental biology of primary human malignant melanomas","volume":"2","author":"Clark","year":"1975","journal-title":"Semin. Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"30","DOI":"10.5114\/pdia.2013.33376","article-title":"Skin melanocytes: Biology and development","volume":"30","author":"Cichorek","year":"2013","journal-title":"Postepy Dermatol. Alergol."},{"key":"ref_3","first-page":"459","article-title":"Dysplastic Nevi\u2014Markers and precursors of malignant melanoma","volume":"147","author":"Crutcher","year":"1987","journal-title":"West. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1098\/rsif.2010.0285","article-title":"The radial growth phase of malignant melanoma: Multi-phase modelling, numerical simulations and linear stability analysis","volume":"8","author":"Ciarletta","year":"2011","journal-title":"J. R. Soc. Interface"},{"key":"ref_5","first-page":"5670","article-title":"Characteristics of cultured human melanocytes isolated from different stages of tumor progression","volume":"45","author":"Herlyn","year":"1985","journal-title":"Cancer Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.5858\/2009-0394-RAR.1","article-title":"Cellular heterogeneity in vertical growth phase melanoma","volume":"134","author":"Laga","year":"2010","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/jcp.1041590208","article-title":"Progressive loss of sensitivity to endothelium-derived growth inhibitors expressed by human melanoma cells during disease progression","volume":"159","author":"Rak","year":"1994","journal-title":"J. Cell. Physiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1600-0749.1987.tb00528.x","article-title":"Biology of melanoma invasion and metastasis","volume":"1","author":"Liotta","year":"1987","journal-title":"Pigment Cell Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s10555-011-9270-7","article-title":"Tumor immunosurveillance in human cancers","volume":"30","author":"Mlecnik","year":"2011","journal-title":"Cancer Metastasis Rev."},{"key":"ref_10","first-page":"279","article-title":"Update on benefit of immunotherapy and targeted therapy in melanoma: The changing landscape","volume":"6","author":"Srivastava","year":"2014","journal-title":"Cancer Manag. Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2326s","DOI":"10.1158\/1078-0432.CCR-05-2517","article-title":"Identifying and overcoming immune resistance mechanisms in the melanoma tumor microenvironment","volume":"12","author":"Gajewski","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1600-065X.1987.tb00521.x","article-title":"Antigen presentation pathways to class I and class II MHC-restricted T lymphocytes","volume":"98","author":"Braciale","year":"1987","journal-title":"Immunol. Rev."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00281-004-0193-z","article-title":"CD4 T cells in tumor immunity","volume":"27","author":"Gerloni","year":"2005","journal-title":"Springer Semin. Immunopathol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/ijc.25270","article-title":"\u201cHard\u201d and \u201csoft\u201d lesions underlying the HLA class I alterations in cancer cells: Implications for immunotherapy","volume":"127","author":"Garrido","year":"2010","journal-title":"Int. J. Cancer"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nature10755","article-title":"Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting","volume":"482","author":"Matsushita","year":"2012","journal-title":"Nature"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1084\/jem.190.5.617","article-title":"Distinct role of antigen-specific T helper type 1 (Th1) and Th2 cells in tumor eradication in vivo","volume":"190","author":"Nishimura","year":"1999","journal-title":"J. Exp. Med."},{"key":"ref_17","first-page":"6438","article-title":"Antigen-specific CD4+ T-cell help is required to activate a memory CD8+ T cell to a fully functional tumor killer cell","volume":"62","author":"Gao","year":"2002","journal-title":"Cancer Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.4049\/jimmunol.174.5.2591","article-title":"CD8+ T cell immunity against a tumor\/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells","volume":"174","author":"Antony","year":"2005","journal-title":"J. Immunol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/nature01441","article-title":"CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes","volume":"421","author":"Janssen","year":"2003","journal-title":"Nature"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"4068","DOI":"10.4049\/jimmunol.144.10.4068","article-title":"Rejection of mouse sarcoma cells after transfection of MHC class II genes","volume":"144","author":"Thakur","year":"1990","journal-title":"J. Immunol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.4049\/jimmunol.147.7.2419","article-title":"Abrogation of tumorigenicity by MHC class II antigen expression requires the cytoplasmic domain of the class II molecule","volume":"147","author":"Roby","year":"1991","journal-title":"J. Immunol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1182\/blood-2007-11-120998","article-title":"Tumor-specific Th17-polarized cells eradicate large established melanoma","volume":"112","author":"Muranski","year":"2008","journal-title":"Blood"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"5901","DOI":"10.1158\/0008-5472.CAN-08-4816","article-title":"Secretion of tumor-specific antigen by myeloma cells is required for cancer immunosurveillance by CD4+ T cells","volume":"69","author":"Corthay","year":"2009","journal-title":"Cancer Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1084\/jem.20091921","article-title":"Naive tumor-specific CD4+ T cells differentiated in vivo eradicate established melanoma","volume":"207","author":"Xie","year":"2010","journal-title":"J. Exp. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/ncomms1239","article-title":"Inflammation driven by tumour-specific Th1 cells protects against B-cell cancer","volume":"2","author":"Haabeth","year":"2011","journal-title":"Nat. Commun."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.immuni.2005.02.003","article-title":"Primary antitumor immune response mediated by CD4+ T cells","volume":"22","author":"Corthay","year":"2005","journal-title":"Immunity"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1084\/jem.20091918","article-title":"Tumor-reactive CD4+ T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts","volume":"207","author":"Quezada","year":"2010","journal-title":"J. Exp. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"5346","DOI":"10.1182\/blood-2006-10-051318","article-title":"CD4 cells can be more efficient at tumor rejection than CD8 cells","volume":"109","author":"Joncker","year":"2007","journal-title":"Blood"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.4049\/jimmunol.133.3.1671","article-title":"The role of tumor-specific Lyt-1+2- T cells in eradicating tumor cells in vivo. I. Lyt-1+2- T cells do not necessarily require recruitment of host\u2019s cytotoxic T cell precursors for implementation of in vivo immunity","volume":"133","author":"Fujiwara","year":"1984","journal-title":"J. Immunol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1084\/jem.161.5.1122","article-title":"Therapy of disseminated murine leukemia with cyclophosphamide and immune Lyt-1+2-T cells. Tumor eradication does not require participation of cytotoxic T cells","volume":"161","author":"Greenberg","year":"1985","journal-title":"J. Exp. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"5700","DOI":"10.1073\/pnas.91.12.5700","article-title":"Naive idiotype-specific CD4+ T cells and immunosurveillance of B-cell tumors","volume":"91","author":"Lauritzsen","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/353622a0","article-title":"Sequence analysis of peptides bound to MHC class II molecules","volume":"353","author":"Rudensky","year":"1991","journal-title":"Nature"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.4049\/jimmunol.145.6.1960","article-title":"Inducible and constitutive MHC class II gene expression. Distinct tissue-specific genetic controls","volume":"145","author":"Sartoris","year":"1990","journal-title":"J. Immunol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.cytogfr.2009.02.004","article-title":"Interferon-\u03b3: A historical perspective","volume":"20","author":"Billiau","year":"2009","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1189\/jlb.0603252","article-title":"Interferon-\u03b3: An overview of signals, mechanisms and functions","volume":"75","author":"Schroder","year":"2004","journal-title":"J. Leukocyte Biol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"14333","DOI":"10.1016\/S0021-9258(17)36621-8","article-title":"Interferon-\u03b3 induces tyrosine phosphorylation of interferon-\u03b3 receptor and regulated association of protein tyrosine kinases, JAK1 and JAK2, with its receptor","volume":"269","author":"Igarashi","year":"1994","journal-title":"J. Biol. Chem."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"17528","DOI":"10.1074\/jbc.270.29.17528","article-title":"The JAK kinases differentially associate with the \u03b1 and \u03b2 (accessory factor) chains of the interferon \u03b3 receptor to form a functional receptor unit capable of activating STAT transcription factors","volume":"270","author":"Sakatsume","year":"1995","journal-title":"J. Biol. Chem."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/0092-8674(94)90357-3","article-title":"Interferon activation of the transcription factor STAT91 involves dimerization through SH2-phosphotyrosyl peptide interactions","volume":"76","author":"Shuai","year":"1994","journal-title":"Cell"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S1359-6101(97)00019-1","article-title":"The growing family of interferon regulatory factors","volume":"8","author":"Nguyen","year":"1997","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1101\/gad.14.9.1156","article-title":"CIITA is a transcriptional coactivator that is recruited to MHC class II promoters by multiple synergistic interactions with an enhanceosome complex","volume":"14","author":"Masternak","year":"2000","journal-title":"Genes Dev."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1128\/MCB.23.9.3091-3102.2003","article-title":"Histone deacetylase 1\/mSin3a disrupts \u03b3 interferon-induced CIITA function and major histocompatibility complex class II enhanceosome formation","volume":"23","author":"Zika","year":"2003","journal-title":"Mol. Cell. Biol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"5125","DOI":"10.1093\/emboj\/cdg496","article-title":"CIITA regulates transcription onset viaSer5-phosphorylation of RNA Pol II","volume":"22","author":"Spilianakis","year":"2003","journal-title":"EMBO J."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/gcc.20728","article-title":"Distinct MHC gene expression patterns during progression of melanoma","volume":"49","author":"Degenhardt","year":"2010","journal-title":"Genes Chromosom. Cancer"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1159\/000327014","article-title":"Mechanisms of tumor and viral immune escape from natural killer cell-mediated surveillance","volume":"3","author":"Groth","year":"2011","journal-title":"J. Innate Immun."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1742-4682-9-31","article-title":"Immunoediting: Evidence of the multifaceted role of the immune system in self-metastatic tumor growth","volume":"9","author":"Enderling","year":"2012","journal-title":"Theor. Biol. Med. Model."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0952-7915(97)80166-5","article-title":"Regulation of transcription of MHC class II genes","volume":"9","author":"Boss","year":"1997","journal-title":"Curr. Opin. Immunol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/gene.2010.74","article-title":"Effect of amino acid substitutions in the human IFN-\u03b32 on IFN-\u03b3 responsiveness","volume":"12","author":"Kilic","year":"2011","journal-title":"Genes Immun."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.jaci.2011.05.043","article-title":"Reduced IFN-\u03b3 receptor expression and attenuated IFN-\u03b3 response by dendritic cells in patients with atopic dermatitis","volume":"128","author":"Gros","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1128\/IAI.70.3.1185-1192.2002","article-title":"Modulation of \u03b3 interferon-induced major histocompatibility complex class II gene expression by porphyromonas gingivalis membrane vesicles","volume":"70","author":"Srisatjaluk","year":"2002","journal-title":"Infect. Immun."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.1128\/MCB.22.13.4781-4791.2002","article-title":"Kinetics of a \u03b3 interferon response: Expression and assembly of CIITA promoter IV and inhibition by methylation","volume":"22","author":"Morris","year":"2002","journal-title":"Mol. Cell. Biol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"e36013","DOI":"10.1371\/journal.pone.0036013","article-title":"Dysregulated recruitment of the histone methyltransferase EZH2 to the class II transactivator (CIITA) promoter IV in breast cancer cells","volume":"7","author":"Truax","year":"2012","journal-title":"PLoS One"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"978","DOI":"10.4161\/rna.20494","article-title":"Dynamic regulation of microRNA expression following interferon-\u03b3-induced gene transcription","volume":"9","author":"Reinsbach","year":"2012","journal-title":"RNA Biol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1471-2407-7-34","article-title":"Distinct mechanisms of loss of IFN-\u03b3 mediated HLA class I inducibility in two melanoma cell lines","volume":"7","author":"Rodriguez","year":"2007","journal-title":"BMC Cancer"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/ijc.1452","article-title":"Rexpression of HLA class I antigens and restoration of antigen-specific CTL response in melanoma cells following 5-aza-2'-deoxycytidine treatment","volume":"94","author":"Serrano","year":"2001","journal-title":"Int. J. Cancer"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1158\/1078-0432.CCR-10-2114","article-title":"Association of IFN-\u03b3 signal transduction defects with impaired HLA class I antigen processing in melanoma cell lines","volume":"17","author":"Respa","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.1167\/iovs.04-0111","article-title":"Epigenetic silencing of the CIITA gene and posttranscriptional regulation of class II MHC genes in ocular melanoma cells","volume":"45","author":"Radosevich","year":"2004","journal-title":"Investig. Ophthalmol. Visual Sci."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1158\/1535-7163.MCT-12-0923","article-title":"Rest negatively and ISGF3 positively regulate the human STAT1 gene in melanoma","volume":"12","author":"Amalraj","year":"2013","journal-title":"Mol. Cancer Ther."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"9881","DOI":"10.1073\/pnas.93.18.9881","article-title":"Identification of potential target genes for the neuron-restrictive silencer factor","volume":"93","author":"Schoenherr","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/gt.2009.10","article-title":"Control by pulse parameters of DNA electrotransfer into solid tumors in mice","volume":"16","author":"Cemazar","year":"2009","journal-title":"Gene Ther."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1089\/hgtb.2011.209","article-title":"Optimization of electroporation-enhanced intradermal delivery of DNA vaccine using a minimally invasive surface device","volume":"23","author":"Lin","year":"2012","journal-title":"Hum. Gene Ther. Methods"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jconrel.2010.07.124","article-title":"mRNA transfection of cervical carcinoma and mesenchymal stem cells mediated by cationic carriers","volume":"147","author":"Rejman","year":"2010","journal-title":"J. Control. Release"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/apm.12293","article-title":"Personalized oncology: Genomic screening in phase 1","volume":"122","author":"Tuxen","year":"2014","journal-title":"APMIS"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2121-9-13","article-title":"Multiple immunofluorescence labelling of formalin-fixed paraffin-embedded (FFPE) tissue","volume":"9","author":"Robertson","year":"2008","journal-title":"BMC Cell Biol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/16\/2\/4343\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T20:42:49Z","timestamp":1760215369000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/16\/2\/4343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,17]]},"references-count":63,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2015,2]]}},"alternative-id":["ijms16024343"],"URL":"https:\/\/doi.org\/10.3390\/ijms16024343","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,17]]}}}